This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1985 Dec 14;291(6510):1687.

doi: 10.1136/bmj.291.6510.1687.

Thrombocytopenia associated with ranitidine

R T Spychal, N W Wickham

PMID: 3935246
PMCID: PMC1418797
DOI: 10.1136/bmj.291.6510.1687

Case Reports

Thrombocytopenia associated with ranitidine

R T Spychal et al. Br Med J (Clin Res Ed). 1985.

. 1985 Dec 14;291(6510):1687.

doi: 10.1136/bmj.291.6510.1687.

Authors

R T Spychal, N W Wickham

PMID: 3935246
PMCID: PMC1418797
DOI: 10.1136/bmj.291.6510.1687

No abstract available

PubMed Disclaimer

Similar articles

Thrombocytopenia associated with hypersensitivity to ranitidine: possible cross-reactivity with cimetidine.
Gafter U, Zevin D, Komlos L, Livni E, Levi J. Gafter U, et al. Am J Gastroenterol. 1989 May;84(5):560-2. Am J Gastroenterol. 1989. PMID: 2719014
Immune-mediated thrombocytopenia associated with ranitidine therapy.
Gibson PR, Pidcock ME. Gibson PR, et al. Med J Aust. 1986 Dec 1-15;145(11-12):661-2. doi: 10.5694/j.1326-5377.1986.tb139552.x. Med J Aust. 1986. PMID: 3796382 No abstract available.
Ranitidine-induced thrombocytopenia.
Bajjoka AE. Bajjoka AE. Arch Intern Med. 1991 Jan;151(1):203. Arch Intern Med. 1991. PMID: 1985602 No abstract available.
H(2) antagonist-induced thrombocytopenia: is this a real phenomenon?
Wade EE, Rebuck JA, Healey MA, Rogers FB. Wade EE, et al. Intensive Care Med. 2002 Apr;28(4):459-65. doi: 10.1007/s00134-002-1233-6. Epub 2002 Mar 12. Intensive Care Med. 2002. PMID: 11967601 Review.
Hypersensitivity reaction to ranitidine: description of a case and review of the literature.
Foti C, Cassano N, Panebianco R, Calogiuri GF, Vena GA. Foti C, et al. Immunopharmacol Immunotoxicol. 2009;31(3):414-6. doi: 10.1080/08923970902739078. Immunopharmacol Immunotoxicol. 2009. PMID: 19694603 Review.

See all similar articles

Cited by

Haematological adverse effects of histamine H2-receptor antagonists.
Aymard JP, Aymard B, Netter P, Bannwarth B, Trechot P, Streiff F. Aymard JP, et al. Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):430-48. doi: 10.1007/BF03259895. Med Toxicol Adverse Drug Exp. 1988. PMID: 2905759 Review.
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.
Grant SM, Langtry HD, Brogden RN. Grant SM, et al. Drugs. 1989 Jun;37(6):801-70. doi: 10.2165/00003495-198937060-00003. Drugs. 1989. PMID: 2667937 Review.
Drug-induced thrombocytopenia in the coronary care unit.
Patnode NM, Gandhi PJ. Patnode NM, et al. J Thromb Thrombolysis. 2000 Oct;10(2):155-67. doi: 10.1023/a:1018766610796. J Thromb Thrombolysis. 2000. PMID: 11005938 Review.
Side effects of ranitidine.
Vial T, Goubier C, Bergeret A, Cabrera F, Evreux JC, Descotes J. Vial T, et al. Drug Saf. 1991 Mar-Apr;6(2):94-117. doi: 10.2165/00002018-199106020-00002. Drug Saf. 1991. PMID: 2043287 Review.
Adverse reactions and interactions with H2-receptor antagonists.
Penston J, Wormsley KG. Penston J, et al. Med Toxicol. 1986 May-Jun;1(3):192-216. doi: 10.1007/BF03259837. Med Toxicol. 1986. PMID: 2878343 Review.

References

1. Lancet. 1976 Dec 18;2(7999):1350 - PubMed
1. Ann Intern Med. 1979 Feb;90(2):264-5 - PubMed
1. Blood. 1981 Sep;58(3):524-9 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Other Literature Sources
- The Lens - Patent Citations Database